OAS3 and melanoma: In addition, the results demonstrated that high expression levels of OAS3 were associated with better PD1 OS in melanoma (Gide2019_PD1, Liu2019_PD1) and better PFS in kidney renal clear cell carcinoma and melanoma (Miao2018_ICB, Liu2019_PD1) (Figures 8B, C).